| answer text |
<p>We are planning for all scenarios in the fight against COVID-19 and the Vaccine
Taskforce is taking a number of steps to ensure the UK is prepared to respond to current
and emerging COVID-19 variants as quickly as possible.</p><p> </p><p>However, current
data suggests that all deployed COVID-19 vaccines in the UK - AstraZeneca, Pfizer
and Moderna - offer protection against the prevalent virus variants currently circulating
in the UK, and recent data indicates that the Pfizer vaccine remains effective against
Beta variant.</p><p> </p><p>We continue to assess the efficacy of the vaccines currently
in our portfolio against new and future variants of the virus and continue to work
closely with vaccine manufacturers to ensure that vaccines that have already received
UK regulatory approval could be suitably updated, where possible and where needed,
to remain effective against emerging variants of SARS-CoV-2.</p>
|
 |
